Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph R. Mikhael, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Emory University Winship Cancer
Atlanta, Georgia, United States
- University of Il at Chicago
Chicago, Illinois, United States
- Mcfarland Clinic
Ames, Iowa, United States
- Siouxland Hematology Oncology Associates
Sioux City, Iowa, United States
- Michigan Cancer Research Consortium and Oncology Research- St. Joseph Mercy Hospital - Ann Arbor
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Mn Ccop
Saint Louis Park, Minnesota, United States
- Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Kinston Medical Specialists
Kinston, North Carolina, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Reading Hospital and Medical Center
West Reading, Pennsylvania, United States
- Wvu Mary Babb Randolph Cancer Center
Morgantown, West Virginia, United States
- Gundersen Lutheran
La Crosse, Wisconsin, United States
- Waukesha Memorial Hospital (prohealth Care)
Waukesha, Wisconsin, United States
- Aurora Cancer Center
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jan 2009
- Primary completion
- 30 Sept 2017
- Completion
- 8 Mar 2018
- Last update posted
- 24 Oct 2018
- Registered enrollment
- 63
- Registry id
- NCT00790842
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.